Trial Profile
A phase I, open-label, 2-period, drug–drug interaction clinical trial investigating the effect of letermovir on the pharmacokinetics of cyclosporin-A and vice versa in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2017
Price :
$35
*
At a glance
- Drugs Letermovir (Primary) ; Ciclosporin
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- 24 Oct 2017 New trial record